Chemical Compound

Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S,4R)-; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S-trans)-; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine; N-Methylparoxetine; BRL-42493; Paroxetine Related Compound F

CAS Registry Number 110429-36-2
返回搜索 申请报价
Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S,4R)-; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S-trans)-; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine; N-Methylparoxetine; BRL-42493; Paroxetine Related Compound F 结构式
Primary record

Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S,4R)-; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S-trans)-; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine; N-Methylparoxetine; BRL-42493; Paroxetine Related Compound F

库存
5,181 克
纯度
99.5 %
CAS
110429-36-2

化合物标识与属性

CAS
110429-36-2
PubChem CID
10947895
SMILES
CN1CC[C@H]([C@@H](C1)COC2=CC3=C(C=C2)OCO3)C4=CC=C(C=C4)F
Canonical SMILES
CN1CC[C@@H](c2ccc(F)cc2)[C@H](COc2ccc3c(c2)OCO3)C1

名称与同义词

  • N-Methylparoxetine
  • N-Methyl Paroxetine
  • 110429-36-2
  • paroxetine
  • Methylparoxetine
  • Paroxetine Related Compound F
  • METHYL PAROXETINE
  • Paroxetine USP Rc F
  • (3S,4R)-N-Methylparoxetine
  • RefChem:163876
  • UNII-3X658583PO
  • trans-(-)-N-methylparoxetine
  • C20H22FNO3
  • MFCD03788781
  • CHEBI:94536
  • MLS001424004
  • DTXSID20149243
  • MOJZPKOBKCXNKG-YJBOKZPZSA-N
  • CHEMBL322363
  • (3S,4R)-N-Methylpa roxetine
  • 3X658583PO
  • DTXCID2071734
  • SCHEMBL30589885
  • HMS2051I12
  • BCP13507
  • HY-Z3832
  • ZINC2586028
  • CM0167
  • CPD000469181
  • AKOS015851047
  • AKOS015889696
  • CCG-100867
  • FM65082
  • NC00117
  • CID10947895
  • AC-18943
  • SAM001246633
  • SMR000469181
  • SY058014
  • PAROXETINE RELATED COMPOUND F [USP-RS]
  • AB1004560
  • J425.849E
  • TC-063875
  • TL8000322
  • CS-0165673
  • FT-0642703
  • M2645
  • PAROXETINE RELATED COMPOUND F (USP-RS)
  • S-7965
  • T71590
  • 429M362
  • F554213
  • A1012781
  • (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine
  • BRD-K19277754-001-01-4
  • Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-,(3S,4R)-
  • Q27166378
  • (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine
  • (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine
  • (3S,4R)-3-((BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)-1-METHYLPIPERIDINE
  • (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)-1-methylpiperidine
  • (3S,4R)-3-(3,4-Methylene-dioxyphenoxy-methyl)-4-(4'-fluorophenyl)-N-methylpiperidine
  • (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-piperidine
  • (3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine
  • (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine
  • Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S,4R)-
  • trans(-)-1-Methyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
  • PIPERIDINE, 3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)-1-METHYL-, (3S,4R)-
  • PIPERIDINE, 3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)-1-METHYL-, (3S-TRANS)-
  • Urea, N-[(8a)-2-bromo-9,10-didehydro-6-methylergolin-8-yl]-N'-ethyl-
  • (3S)-1-Methyl-3beta-(1,3-benzodioxole-5-yloxymethyl)-4alpha-(4-fluorophenyl)piperidine
  • (3S,4R)-(-)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine
  • (3S,4R)-(-)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl]-1-methylpiperidine
  • (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)-1-methyl-piperidine
  • (3S,4R)-3-[(1,3-Benzodioxole-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine
  • (3S,4R)-3-[[(1,3-Benzodioxol-5-yl)oxy]methyl]-4alpha-(4-fluorophenyl)-1-methylpiperidine
  • (3S,4R)-3-{[(2H-1,3-Benzodioxol-5-yl)oxy]methyl}-4-(4-fluorophenyl)-1-methylpiperidine
  • (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine
  • Paroxetine Related Compound F, United States Pharmacopeia (USP) Reference Standard
  • Piperidina, 3-[(1,3-benzodioxol-5-iloxi)metil]-4-(4-fluorofenil)-1-metil-, (3s,4r)-
  • Trans-(-)-3-((1,3-Benzodioxol-5-yloxyl)-Methyl)-4-(4-FluoroPhenyl)-1-methyl Piperidine
  • Trans-(-)-3-[(1,3-Benzodioxol-5-yloxyl)-Methyl]-4-(4-FluoroPhenyl)-1-methyl Piperidine
  • (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine (Paroxetine Impurity
  • (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine? (Paroxetine Impurity pound(c)
  • 110429-51-1
  • 600-963-2
  • N-Methylparoxetine; (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-Piperidine; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine
  • Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S,4R)-; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S-trans)-; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine; N-Methylparoxetine; BRL-42493; Paroxetine Related Compound F
  • trans-(-)-4-(4'-FLUORO PHENYL)-3-[[3,4-(METHYLENEDIOXY)- PHENOXY]-METHYL]-N-METHYLPIPERIDINE